News

In 2022 alone, chemical abortions accounted for 63% of all abortions in the United States, totaling 642,700 . Shockingly, ...
A woman who “found” her toddler “unresponsive” in her playpen and alerted a mail carrier outside her Washington, D.C., ...
The FDA has approved Widaplik, a triple-drug combination, for the treatment of hypertension in adults.
Toms River's Teddy Golubowski was excelling in the academy until he suddenly was diagnosed with a rare cancer. Here's how the ...
Inside the small courtyard on Franciscan Health Indianapolis’ campus, a statue of St. Francis looks out over grass, stone and ...
In the U.S., the maternal mortality rate is greater than in other high-income countries, with persistent racial and ethnic ...
Abortion rights advocates in Kentucky are concerned as the Department of Health and Human Services has revoked a policy ...
FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as ...
Viz.ai announced it has received FDA 510(k) clearance for Viz Subdural Plus, a comprehensive solution for quantifying the ...
A mother from DC has been convicted of murdering her 16-month-old daughter Rhythm Fields, who was found lifeless and cold ...
The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.
The FDA has approved a tablet version of zanubrutinib for all indications, improving convenience and reducing pill burden for patients with blood cancers.